Skip to content
Open access · OA via OpenAlex

NAD<sup>+</sup>: A key metabolic regulator with great therapeutic potential

Ghazal Sultani, Azrah Samsudeen, Brenna Osborne, Nigel Turner

Journal of Neuroendocrinology · 2017 · ▲ 49 citations

Abstract

Nicotinamide adenine dinucleotide ( NAD + ) is a ubiquitous metabolite that serves an essential role in the catabolism of nutrients. Recently, there has been a surge of interest in NAD + biology, with the recognition that NAD + influences many biological processes beyond metabolism, including transcription, signalling and cell survival. There are a multitude of pathways involved in the synthesis and breakdown of NAD + , and alterations in NAD + homeostasis have emerged as a common feature of a range of disease states. Here, we provide an overview of NAD + metabolism and summarise progress on the development of NAD + ‐related therapeutics.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1111/jne.12508
Canonical
link ↗
Fetched
2026-06-16 MST

Cite this

APA
Sultani, G., Samsudeen, A., Osborne, B., &amp; Turner, N. (2017). NAD<sup>+</sup>: A key metabolic regulator with great therapeutic potential. <em>Journal of Neuroendocrinology</em>. https://doi.org/10.1111/jne.12508
Vancouver
Sultani G, Samsudeen A, Osborne B, Turner N. NAD<sup>+</sup>: A key metabolic regulator with great therapeutic potential. Journal of Neuroendocrinology. 2017. doi:10.1111/jne.12508.
BibTeX
@article{ghazal2017NADsup, title = {NAD<sup>+</sup>: A key metabolic regulator with great therapeutic potential}, author = {Ghazal Sultani and Azrah Samsudeen and Brenna Osborne and Nigel Turner}, journal = {Journal of Neuroendocrinology}, year = {2017}, doi = {10.1111/jne.12508}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings